OS Therapies Incorporated OSTX
0.89 USD -0.03 (-3.27%)
At closeNov 11, 2026, 4:21 AM EST
0.95 +0.06 +6.90%
Pre-market · Nov 11, 4:21 AM ET
0.8601 Day range 0.98005
0.58 52-week range 2.25
- YTD
- -36.43%
- 1 year
- -52.91%
News
benzinga.com OS Therapies Initiates CMAA Process With UK MHRA For Herlystic In Prevention Or Delay Of Recurrence In Fully Resected, Pulmonary Metastatic Osteosarcoma; Expects To Complete CMAA Process Later In Q4 Of 2026 US Based Clinical Stage Oncology Company Begins Critical Step Following Successful September 2026 Scientific Advice MeetingSubmission expected to be accepted in the fourth quarter of 2026Potential…
newsfilecorp.com OS Therapies Initiates U.K. MHRA Conditional Marketing Authorisation Application for Herlystic (OST-HER2) in the Prevention or Delay of Recurrence in Fully Resected, Pulmonary Metastatic Osteosarcoma US Based Clinical Stage Oncology Company Begins Critical Step Following Successful September 2026 Scientific Advice Meeting Submission expected to be accepted in the fourth quarter of 2026 Potential…
newsfilecorp.com OS Therapies Completes Requalification of Phase 2b Herlystic (OST-HER2) Drug Substance for Confirmatory Phase 3 Trial Leading Clinical Stage Oncology Company Now Able to Complete CMMA Submission to U.K's MHRA for Early Commercial Access and Trial Authorisation Grasonville, Maryland--(Newsfile Corp. - November 5,…